Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug safety
Pharma
Fresenius Kabi launches US recall of Actemra biosimilar
Shortly after initiating a separate recall tied to mislabeled pain medicine, Fresenius Kabi is yanking a batch of another product in the U.S.
Fraiser Kansteiner
Aug 12, 2026 9:13am
Fresenius Kabi recalls morphine lot that could lead to death
Aug 7, 2026 9:30am
RFK Jr.'s Gardasil lawsuit ties back under lawmaker microscope
Jul 30, 2026 9:50am
Peptide adcomm Day 2: Emideltide fails to make grade in vote
Jul 24, 2026 2:00pm
Amgen submits analyses to FDA in bid for Tavneos hearing
Jul 24, 2026 10:50am
HHS proposes creating table of COVID vaccine injuries
Jul 9, 2026 11:08am